547 related articles for article (PubMed ID: 30343150)
1. Therapeutic potential of targeting the Eph/ephrin signaling complex.
Saha N; Robev D; Mason EO; Himanen JP; Nikolov DB
Int J Biochem Cell Biol; 2018 Dec; 105():123-133. PubMed ID: 30343150
[TBL] [Abstract][Full Text] [Related]
2. Eph receptors and ephrins: therapeutic opportunities.
Barquilla A; Pasquale EB
Annu Rev Pharmacol Toxicol; 2015; 55():465-87. PubMed ID: 25292427
[TBL] [Abstract][Full Text] [Related]
3. Eph receptors and ephrins as targets for cancer therapy.
Xi HQ; Wu XS; Wei B; Chen L
J Cell Mol Med; 2012 Dec; 16(12):2894-909. PubMed ID: 22862837
[TBL] [Abstract][Full Text] [Related]
4. Ephrin or not? Six tough questions on Eph targeting.
Giorgio C; Zanotti I; Lodola A; Tognolini M
Expert Opin Ther Targets; 2020 May; 24(5):403-415. PubMed ID: 32197575
[No Abstract] [Full Text] [Related]
5. The role of ephrins and Eph receptors in cancer.
Surawska H; Ma PC; Salgia R
Cytokine Growth Factor Rev; 2004 Dec; 15(6):419-33. PubMed ID: 15561600
[TBL] [Abstract][Full Text] [Related]
6. Antibodies binding the ADAM10 substrate recognition domain inhibit Eph function.
Atapattu L; Saha N; Llerena C; Vail ME; Scott AM; Nikolov DB; Lackmann M; Janes PW
J Cell Sci; 2012 Dec; 125(Pt 24):6084-93. PubMed ID: 23108669
[TBL] [Abstract][Full Text] [Related]
7. Ephrin-Eph signaling usage by a variety of viruses.
de Boer ECW; van Gils JM; van Gils MJ
Pharmacol Res; 2020 Sep; 159():105038. PubMed ID: 32565311
[TBL] [Abstract][Full Text] [Related]
8. Targeting Eph/ephrin system in cancer therapy.
Lodola A; Giorgio C; Incerti M; Zanotti I; Tognolini M
Eur J Med Chem; 2017 Dec; 142():152-162. PubMed ID: 28780190
[TBL] [Abstract][Full Text] [Related]
9. Eph/Ephrin Signaling in the Tumor Microenvironment.
Ieguchi K; Maru Y
Adv Exp Med Biol; 2021; 1270():45-56. PubMed ID: 33123992
[TBL] [Abstract][Full Text] [Related]
10. Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond.
Lamminmaki U; Nikolov D; Himanen J
Curr Drug Targets; 2015; 16(10):1021-30. PubMed ID: 26028047
[TBL] [Abstract][Full Text] [Related]
11. Eph-ephrin bidirectional signaling in physiology and disease.
Pasquale EB
Cell; 2008 Apr; 133(1):38-52. PubMed ID: 18394988
[TBL] [Abstract][Full Text] [Related]
12. Eph receptor and ephrin function in breast, gut, and skin epithelia.
Perez White BE; Getsios S
Cell Adh Migr; 2014; 8(4):327-38. PubMed ID: 25482622
[TBL] [Abstract][Full Text] [Related]
13. Of Ephs and ephrins: companies target guidance molecules in cancer.
Garber K
J Natl Cancer Inst; 2010 Nov; 102(22):1692-4. PubMed ID: 21060063
[No Abstract] [Full Text] [Related]
14. Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation.
Nikolov DB; Xu K; Himanen JP
Biochim Biophys Acta; 2013 Oct; 1834(10):2160-5. PubMed ID: 23628727
[TBL] [Abstract][Full Text] [Related]
15. Ephrins and Eph Receptor Signaling in Tissue Repair and Fibrosis.
Wu B; Rockel JS; Lagares D; Kapoor M
Curr Rheumatol Rep; 2019 Apr; 21(6):23. PubMed ID: 30980212
[TBL] [Abstract][Full Text] [Related]
16. Eph receptors and ephrins in cancer: bidirectional signalling and beyond.
Pasquale EB
Nat Rev Cancer; 2010 Mar; 10(3):165-80. PubMed ID: 20179713
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Eph System with Peptides and Peptide Conjugates.
Riedl SJ; Pasquale EB
Curr Drug Targets; 2015; 16(10):1031-47. PubMed ID: 26212263
[TBL] [Abstract][Full Text] [Related]
18. The Evolutionary History of Ephs and Ephrins: Toward Multicellular Organisms.
Arcas A; Wilkinson DG; Nieto MÁ
Mol Biol Evol; 2020 Feb; 37(2):379-394. PubMed ID: 31589243
[TBL] [Abstract][Full Text] [Related]
19. Eph/ephrin signaling in cancer: intricate, puzzling and ... fascinating!
Alonso-Colmenar LM
Cell Adh Migr; 2012; 6(2):100-1. PubMed ID: 22814609
[TBL] [Abstract][Full Text] [Related]
20. Regulation and misregulation of Eph/ephrin expression.
Arvanitis DN; Davy A
Cell Adh Migr; 2012; 6(2):131-7. PubMed ID: 22568953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
